Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) reports the results of the company's Annual General Meeting (AGM) held on May 7, 2014. The filing confirms that all shareholder resolutions presented at the meeting were passed.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance report regarding AGM voting outcomes rather than a financial performance statement.
Material Changes and Voting Results
All 25 resolutions were approved by shareholders. Key voting statistics include:
- Financial Statements: The adoption of the Directors' Report and Financial Statements received 98.85% support.
- Remuneration: The Remuneration Report was approved by 98.52% of votes, and the Directors' Remuneration Policy by 97.42%.
- Board Composition: Sir Robert Wilson did not stand for re-election and stepped down from the Board. All other directors seeking re-election were approved, with support ranging from 91.57% (Hans Wijers) to 99.91% (Lynn Elsenhans and Jing Ulrich).
- Shareholder Participation: Total votes cast and withheld represented 74.05% of issued share capital, a decrease from 76.50% in the 2013 AGM.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or discussion of risks and contingencies. It strictly details the procedural outcomes of the AGM and the re-election of the board.
Investor Verification Checklist
- Verify the specific vote counts for the re-election of directors with lower approval rates, specifically Hans Wijers (91.57%) and Tom de Swaan (98.30%).
- Confirm the departure of Sir Robert Wilson from the Board effective immediately following the AGM.
- Review the full text of the Directors' Report and Financial Statements referenced in Resolution 1, as the filing only confirms their adoption.
- Check the company website for the full text of special resolutions regarding share allotment and pre-emption rights disapplication.